Hematologic Neoplasms

"Hematologic Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES.

Descriptor ID	D019337
MeSH Number(s)	C04.588.448 C15.378.400
Concept/Terms	Hematologic Neoplasms Hematologic Neoplasms Hematologic Malignancy Neoplasms, Hematologic Hematologic Neoplasm Neoplasm, Hematologic Hematological Neoplasms Hematological Neoplasm Neoplasm, Hematological Neoplasms, Hematological Malignancies, Hematologic Malignancy, Hematologic Hematologic Malignancies Hematological Malignancies Hematological Malignancy Malignancies, Hematological Malignancy, Hematological Hematopoietic Neoplasms Hematopoietic Neoplasms Neoplasms, Hematopoietic Hematopoietic Neoplasm Neoplasm, Hematopoietic Hematopoietic Malignancies Hematopoietic Malignancy Malignancies, Hematopoietic Malignancy, Hematopoietic

Below are MeSH descriptors whose meaning is more general than "Hematologic Neoplasms".

Below are MeSH descriptors whose meaning is more specific than "Hematologic Neoplasms".

Hematologic Neoplasms
Bone Marrow Neoplasms

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Hematologic Neoplasms" by people in this website by year, and whether "Hematologic Neoplasms" was a major or minor topic of these publications.

Bar chart showing 40 publications over 18 distinct years, with a maximum of 4 publications in 2019 and 2020 and 2022 and 2023 and 2024

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1999	1	0	1
2002	1	0	1
2004	0	1	1
2008	1	0	1
2010	0	1	1
2012	2	0	2
2013	2	0	2
2015	1	0	1
2016	1	0	1
2017	1	1	2
2018	2	0	2
2019	3	1	4
2020	4	0	4
2021	2	0	2
2022	4	0	4
2023	4	0	4
2024	3	1	4
2025	3	0	3

Below are the most recent publications written about "Hematologic Neoplasms" by people in Profiles.

Diamond B, Chahar D, Jain MD, Poos AM, Durante MA, Ziccheddu B, Kaddoura M, Papadimitriou M, Maclachlan KH, Jelinek T, Davies FE, Figura NB, Morgan GJ, Mai EK, Weisel K, Fenk R, Raab MS, Usmani S, Landgren O, Locke FL, Goldschmidt H, Schatz JH, Weinhold N, Maura F. Mutagenic Impact and Evolutionary Influence of Chemoradiotherapy in Hematologic Malignancies. Blood Cancer Discov. 2025 Sep 03; 6(5):450-463.

View in: PubMed
Einarsdottir S, Lobaugh S, Luan D, Gomez-Llobell M, Subramanian P, Devlin S, Chung D, Dahi PB, Falchi L, Giralt S, Landau H, Lesokhin AM, Lin R, Lue J, Mailankody S, Palomba ML, Park JH, Salles G, Scordo M, Escribano-Serrat S, Sanz J, Rejeski K, Shouval R, Usmani S, Perales MA, Shah G, Shahid Z. Humoral vaccine responses following Chimeric Antigen Receptor T-cell therapy for hematological malignancies. Blood Cancer J. 2025 Jul 02; 15(1):114.

View in: PubMed
Flynn EN, Dadras SS, Petty A, Olugbade ID, Imahiyerobo-Ip J. Blastic plasmacytoid dendritic cell neoplasm. Dermatol Online J. 2025 Feb 15; 31(1).

View in: PubMed
Grunwald MR, Sha W, He J, Sanikommu S, Gerber JM, Ai J, Knight TG, Fasan O, Boseman V, Kaizen W, Chojecki A, Ragon BK, Symanowski J, Avalos B, Copelan E, Ghosh N. Biologically Randomized Comparison of Haploidentical Versus Human Leukocyte Antigen-Matched Related Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation. Transplant Cell Ther. 2024 12; 30(12):1211.e1-1211.e11.

View in: PubMed
Hsieh TC, Yeo YH, Zou G, Zhou C, Ash A. Disparities in Palliative Care Use for Patients With Blood Cancer Who Died in the Hospital. Am J Hosp Palliat Care. 2025 Mar; 42(3):236-243.

View in: PubMed
Bindal P, Patell R, Chiasakul T, Lauw MN, Ko A, Wang TF, Zwicker JI. A meta-analysis to assess the risk of bleeding and thrombosis following chimeric antigen receptor T-cell therapy: Communication from the ISTH SSC Subcommittee on Hemostasis and Malignancy. J Thromb Haemost. 2024 Jul; 22(7):2071-2080.

View in: PubMed
Heybati K, Deng J, Bhandarkar A, Zhou F, Zamanian C, Arya N, Bydon M, Bauer PR, Gajic O, Walkey AJ, Yadav H. Outcomes of Acute Respiratory Failure in Patients With Cancer in the United States. Mayo Clin Proc. 2024 Apr; 99(4):578-592.

View in: PubMed
Ahmad MH, Hegde M, Wong WJ, Mohammadhosseini M, Garrett L, Carrascoso A, Issac N, Ebert B, Silva JC, Pihan G, Zhu LJ, Wolfe SA, Agarwal A, Liu PP, Castilla LH. Runx1-R188Q germ line mutation induces inflammation and predisposition to hematologic malignancies in mice. Blood Adv. 2023 12 12; 7(23):7304-7318.

View in: PubMed
Sadigh S, DeAngelo DJ, Garcia JS, Hasserjian RP, Hergott CB, Lane AA, Lovitch SB, Lucas F, Luskin MR, Morgan EA, Pinkus GS, Pozdnyakova O, Rodig SJ, Shanmugam V, Tsai HK, Winer ES, Zemmour D, Kim AS. Cutaneous Manifestations of Myeloid Neoplasms Exhibit Broad and Divergent Morphologic and Immunophenotypic Features but Share Ancestral Clonal Mutations With Bone Marrow. Mod Pathol. 2024 Jan; 37(1):100352.

View in: PubMed
Massicotte-Azarniouch D, Detwiler RK, Hu Y, Falk RJ, Saha MK, Hogan SL, Derebail VK. Malignancy risk in kidney transplant recipients exposed to immunosuppression pre-transplant for the treatment of glomerulonephritis. Nephrol Dial Transplant. 2023 08 31; 38(9):2009-2018.

View in: PubMed

People

Explore

Similar Concepts

Top Journals